Pentadecapeptide
Also known as BPC-157 Full Sequence, Stable Gastric Pentadecapeptide
The full 15-amino acid sequence containing BPC-157, derived from gastric juice with comparable healing properties.
Regulatory Pathway
Dosing Protocol
Typical Dose
250-500 mcg twice daily
Frequency
1-2x daily
Duration
4-12 weeks typical
Timing & Administration
Administer via Subcutaneous injection. Frequency: 1-2x daily.
Popular Uses
Mechanism of Action
Modulates the nitric oxide system, promotes angiogenesis, and accelerates tissue healing. Interacts with multiple growth factor systems and has cytoprotective effects on various tissues.
Research Summary
Evidence level: animal studies. Clinical status: Preclinical - Same research base as BPC-157.
Side Effects & Safety
Important Warnings
- Caution with MCAS or histamine sensitivity
References
No references available.
Related Peptides
Browse all →A synthetic peptide derived from a protein found in human gastric juice. Extensive preclinical studies demonstrate efficacy in healing tendons, ligaments, muscles, and the GI tract.
View profileA synthetic 17-amino acid fragment of Thymosin Beta-4 with a longer half-life (~2-4 days) compared to the full protein (~2 hours).
View profileA synthetic cone snail venom peptide for severe chronic pain. The first intrathecal non-opioid analgesic FDA approved.
View profile